Edition:
United Kingdom

Alpine Immune Sciences Inc (ALPN.OQ)

ALPN.OQ on NASDAQ Stock Exchange Global Market

8.20USD
19 Apr 2018
Change (% chg)

$0.49 (+6.36%)
Prev Close
$7.71
Open
$7.65
Day's High
$8.22
Day's Low
$7.65
Volume
2,104
Avg. Vol
5,367
52-wk High
$12.82
52-wk Low
$7.30

Chart for

About

Alpine Immune Sciences, Inc., formerly Nivalis Therapeutics, Inc., is focused on developing a protein-based immunotherapies using Variant immunoglobulin domain (vlgD) platform technology. The vlgD platform is designed to interact with multiple targets, including many present in the immune synapse. The vlgDs are developed using a... (more)

Overall

Beta: --
Market Cap(Mil.): $168.94
Shares Outstanding(Mil.): 13.88
Dividend: --
Yield (%): --

Financials

  ALPN.OQ Industry Sector
P/E (TTM): -- 84.02 32.74
EPS (TTM): -6.42 -- --
ROI: -48.40 1.58 14.38
ROE: -48.40 2.41 16.07

BRIEF-Alpine Immune Sciences Provides Corporate Update And Reports Full Year 2017 Financial Results

* ALPINE IMMUNE SCIENCES PROVIDES CORPORATE UPDATE AND REPORTS FULL YEAR 2017 FINANCIAL RESULTS

28 Mar 2018

Earnings vs. Estimates